Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Jenner

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
British Journal of Haematology|June 12, 2020
Early relapse after high-dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high-risk disease in multiple myelomaCeri Bygrave, Charlotte Pawlyn, Faith Davies, et al.
Microbial Genomics|January 18, 2021
Kill and cure: genomic phylogeny and bioactivity of <i>Burkholderia gladioli</i> bacteria capable of pathogenic and beneficial lifestylesCerith Jones, Gordon Webster, Alex J Mullins, et al.
Chembiochem : a European Journal of Chemical Biology|April 21, 2011
Mechanism-based inhibition of quinone reductase 2 (NQO2): selectivity for NQO2 over NQO1 and structural basis for flavoprotein inhibitionMarine Dufour, Chao Yan, David Siegel, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 22, 2023
A phase 1b dose-escalation study of carfilzomib in combination with thalidomide and dexamethasone in patients with relapsed/refractory systemic immunoglobulin light chain amyloidosisSriram Ravichandran, Andrew Hall, Matthew Jenner, et al.
Clinical and Experimental Immunology|June 27, 2026
Case Series on the Efficacy of Daratumumab in Treating Patients with Anti-Interferon-Gamma AutoantibodiesKy-Lyn Tan, Hari Chandana Ghanta, Lucinda Blake, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 1, 2021
Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes: Results from 3894 Patients in the Myeloma XI TrialSarah Bird, David Cairns, Tom Menzies, et al.
JACS Au|January 31, 2025
Molecular Basis for Short-Chain Thioester Hydrolysis by Acyl Hydrolases in <i>trans</i>-Acyltransferase Polyketide SynthasesChristopher D Fage, Munro Passmore, Ben P Tatman, et al.
British Journal of Haematology|May 8, 2014
Updates to the guidelines for the diagnosis and management of multiple myelomaGuy Pratt, Matthew Jenner, Roger Owen, et al.
Mbio|August 3, 2021
Discovery of the Pseudomonas Polyyne Protegencin by a Phylogeny-Guided Study of Polyyne Biosynthetic Gene Cluster DiversityAlex J Mullins, Gordon Webster, Hak Joong Kim, et al.
Nature Microbiology|March 6, 2019
Genome mining identifies cepacin as a plant-protective metabolite of the biopesticidal bacterium Burkholderia ambifariaAlex J Mullins, James A H Murray, Matthew J Bull, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
British Journal of Haematology|June 12, 2020
Early relapse after high-dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high-risk disease in multiple myelomaCeri Bygrave, Charlotte Pawlyn, Faith Davies, et al.
Microbial Genomics|January 18, 2021
Kill and cure: genomic phylogeny and bioactivity of <i>Burkholderia gladioli</i> bacteria capable of pathogenic and beneficial lifestylesCerith Jones, Gordon Webster, Alex J Mullins, et al.
Chembiochem : a European Journal of Chemical Biology|April 21, 2011
Mechanism-based inhibition of quinone reductase 2 (NQO2): selectivity for NQO2 over NQO1 and structural basis for flavoprotein inhibitionMarine Dufour, Chao Yan, David Siegel, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 22, 2023
A phase 1b dose-escalation study of carfilzomib in combination with thalidomide and dexamethasone in patients with relapsed/refractory systemic immunoglobulin light chain amyloidosisSriram Ravichandran, Andrew Hall, Matthew Jenner, et al.
Clinical and Experimental Immunology|June 27, 2026
Case Series on the Efficacy of Daratumumab in Treating Patients with Anti-Interferon-Gamma AutoantibodiesKy-Lyn Tan, Hari Chandana Ghanta, Lucinda Blake, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 1, 2021
Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes: Results from 3894 Patients in the Myeloma XI TrialSarah Bird, David Cairns, Tom Menzies, et al.
JACS Au|January 31, 2025
Molecular Basis for Short-Chain Thioester Hydrolysis by Acyl Hydrolases in <i>trans</i>-Acyltransferase Polyketide SynthasesChristopher D Fage, Munro Passmore, Ben P Tatman, et al.
British Journal of Haematology|May 8, 2014
Updates to the guidelines for the diagnosis and management of multiple myelomaGuy Pratt, Matthew Jenner, Roger Owen, et al.
Mbio|August 3, 2021
Discovery of the Pseudomonas Polyyne Protegencin by a Phylogeny-Guided Study of Polyyne Biosynthetic Gene Cluster DiversityAlex J Mullins, Gordon Webster, Hak Joong Kim, et al.
Nature Microbiology|March 6, 2019
Genome mining identifies cepacin as a plant-protective metabolite of the biopesticidal bacterium Burkholderia ambifariaAlex J Mullins, James A H Murray, Matthew J Bull, et al.
Pageof 8